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AT THE FOCAL POINT264Massimo Raimondo, MD, Associate Editor for Focal PointsA truly visible vessel in an endoscopic submucosal dissection scare:
thinking outside recommendationsA 75-year-old woman with a superﬁcial lesion type IIaþc
(intramucosal adenocarcinoma) 12  15 mm in diameter
in the incisura angularis (A) was admitted for endoscopic
submucosal dissection (ESD). During the procedure,
mild bleeding was observed, which was controlled by
vessel coagulation by use of the dissection IT knife
(Olympus, Tokyo, Japan). Later, in the posterior area, a
big vessel, approximately 3 mm in diameter, was seen
(B). The decision was made not to coagulate that vessel
immediately, to dissect around the vessel, and to complete
en bloc resection. Upon completion of the ESD, a ﬁne
layer of submucosa was apparent over the vessel without
bleeding (C). Even though the team was aware of the sug-
gestion to coagulate the visible vessels in the artiﬁcial
ulcer, the decision was not to coagulate that particularGASTROINTESTINAL ENDOSCOPY Volume 83, No. 1 : 2016
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For personal use only. No other uses without permission. vessel, given its big caliber and extension, knowing that if
bleeding had occurred, its management would not be
straightforward. The patient remained hemodynamically
stable. After 1 month of follow-up, no signs of bleeding
were noticeable. We estimate that more cases like this
occur in daily practice because some patients’ clinical
situations have not been completely described in previous
studies, and thus those cases have no supporting
recommendations.DISCLOSURE
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Gastric cancer is the fourth most common cancer in both sexes worldwide. Early gastric cancer (EGC) is deﬁned as cancer
limited to the mucosa or submucosa. The prognosis of EGC is good, with the 5-year gastric cancer–speciﬁc survival rate
reportedly 99% if the cancer is resected successfully. Local and less invasive methods to remove the cancer would be indi-
cated in those cancers limited to the mucosa with negligible risk of lymph node metastasis. Most of the time, endoscopic
resection is considered curative when submucosal invasion is limited to 500 mm in depth. Two endoscopic resection tech-
niques are used to remove EGC, including EMR and endoscopic submucosal dissection (ESD). ESD allows for en bloc com-
plete resection of larger lesions (>2 cm) and avoids piecemeal resection. This is crucial because the local recurrence rate is
15% when en bloc resection is not achieved. By achieving en bloc resection, it allows for detailed histopathologic assess-
ment, which is required to conﬁrm curative resection. This procedure helps preserve the stomach and avoid gastrectomy.
ESD has replaced EMR for the removal of most gastric lesions. Adverse events associated with endoscopic resection of EGC
include bleeding and perforation. Bleeding after ESD can be classiﬁed into immediate (during the procedure) or delayed
(within 2 weeks or later). More than 76% of delayed bleeding episodes take place within the ﬁrst 24 hours after the pro-
cedure. Both immediate and delayed bleeding are more common in gastric ESD because of the increased submucosal ves-
sels in this area. In addition, gastric lesions in the middle or upper third of the stomach are at increased risk. For immediate
bleeding, electrocautery is used for hemostasis because endoscopic clips interfere with the subsequent resection proce-
dure. Electrocautery can be carried out with different devices. Minor oozing can be controlled by using electrocautery cut-
ting devices such as IT, hook, or dual knife. A critical point in achieving good hemostasis is to identify the exact bleeding
point, using water ﬂushing. Prophylactic electrocautery of large submucosal vessels during ESD has been demonstrated to
decrease the risk of delayed bleeding up to 60%. For post-ESD coagulation, this is achieved by using hemostatic forceps
such as a coagrasper or hot biopsy forceps. In one study, post-ESD coagulation therapy was applied to visible vessels
regardless of whether there was any evidence of bleeding at the end of ESD. The study demonstrates that prophylactic
treatment of visible vessels appears to be an important factor for prevention of delayed bleeding after ESD. In the case
presented, the authors decided not to perform prophylactic coagulation of the visible vessel after the ESD. On the basis
of current literature and guidelines, it is suggested that prophylactic therapy leads to a decreased risk of bleeding later
on. Additional studies need to be performed to conﬁrm the ﬁnding of the current case, particularly for challenging patients
who are receiving long-term anticoagulant agents.
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Associate Editor for Focal PointsDirect digital cholangioscopic visualization of suture causing
a biliary anastomotic strictureA 61-year-old man underwent orthotopic liver transplan-
tation for end-stage liver disease and cirrhosis resulting from
alcohol abuse. He did well in the immediate postoperative
period, but 4 weeks after transplantation he experienced
jaundice and elevated liver chemistry determinations with
a cholestatic pattern. ERCP demonstrated a tight anasto-
motic stricture with donor intrahepatic and extrahepaticductal dilatation. An 8.5F plastic biliary stent was
placed, with improvement in his liver chemistry determina-
tions and resolution of jaundice. On repeated ERCP,
there was decreased intrahepatic ductal dilatation, but
the anastomotic stricture persisted (A). The Spyglass
digital cholangioscope (Boston Scientiﬁc, Natick, Mass)
was used to examine the stenosis. Cholangiographically,Volume 83, No. 1 : 2016 GASTROINTESTINAL ENDOSCOPY 265
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